IL21 and neoplasm: Namely, there has been an increase in T follicular helper cells and a decrease in pro-inflammatory IL-21 in patients’ serum, which indicates impaired function of these cells, possibly causing further immunosuppression and leading to tumor progression in NSCLC [102].